2016
DOI: 10.4049/jimmunol.1501061
|View full text |Cite
|
Sign up to set email alerts
|

The Expression of BAFF Is Controlled by IRF Transcription Factors

Abstract: Patients with systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) are typically characterized by the presence of autoantibodies and an IFN-signature. The strength of the IFN-signature positively correlates with disease severity, suggesting that type I IFNs are active players in these diseases. BAFF is a cytokine critical for development and proper selection of B cells, and the targeting of BAFF has emerged as a successful treatment strategy of SLE. Previous reports have suggested that BAFF … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
55
2
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 81 publications
(63 citation statements)
references
References 27 publications
3
55
2
2
Order By: Relevance
“…Nevertheless, it has become clear from these studies that BAFF production is triggered by stimulation with type I and II interferons, which corresponds with our results showing interferon-induced BAFF secretion from decidual stromal cells. Indeed, BAFF expression is directly downstream of type I IFN signaling and members of the IFN regulatory factor family regulate BAFF53. However, since neither cord blood nor maternal-derived decidual mononuclear cells produced BAFF when stimulated with either IFN-γ or IFN-α in the present study, circulating immune cells in the fetus and mother are most likely not the main source for cord blood BAFF levels.…”
Section: Discussionmentioning
confidence: 60%
“…Nevertheless, it has become clear from these studies that BAFF production is triggered by stimulation with type I and II interferons, which corresponds with our results showing interferon-induced BAFF secretion from decidual stromal cells. Indeed, BAFF expression is directly downstream of type I IFN signaling and members of the IFN regulatory factor family regulate BAFF53. However, since neither cord blood nor maternal-derived decidual mononuclear cells produced BAFF when stimulated with either IFN-γ or IFN-α in the present study, circulating immune cells in the fetus and mother are most likely not the main source for cord blood BAFF levels.…”
Section: Discussionmentioning
confidence: 60%
“…There are many genes known to be affected by downstream of IFN signalling, several of which were upregulated in our set of genes such as chemokines ( Ccl5, Ccl12, Cxcl9, Cxcl10 )2223, cytokines ( TNFSF13B )24, proteins involved in antigen presentation ( H2-Q8, H2-sg17, H2-Q7, H2-Q2, H2-Q5, H2-K1, H2-T23, H2-D1, H2-D4, H2Q5, H2T22, H2T23, H2T4 )25, transcription factors (STAT2, IRF1) and Interferon induced IFIT, IFITM and OAS (IFIT2, IFIT3, IFITM1, IFITM2, IFITM3, Oas1, Oas2, Oals1). Interestingly, Type I IFN receptor (IFNAR) exhibited upregulation in our dataset.…”
Section: Resultsmentioning
confidence: 99%
“…At cytokine level, T1-IFNs can induce the production of B-cell activating factor (BAFF) by myeloid cells (238, 260, 261). BAFF induction confers a significant proportion of T1-IFN-mediated damage in SLE as supported by the observation that IFN-α administration induces disease in SLE-prone mice but fails to do so in B-cell-deficient and BAFF-deficient mice on the same background (262).…”
Section: T1-ifns the Th17 Response And Their Interactions In Autoimmmentioning
confidence: 99%